$AVNR Recent News U.S. stock futures cut rise after

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2014 at 10:56 AM

$AVNR Recent News

U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy
Avanir Pharmaceuticals shares up 85% 9:41 a.m. Aug. 11, 2009 - Nick Godt
Avanir climbs on Phase III Zenvia trial success 7:31 a.m. Aug. 11, 2009 - Steve Goldstein

Avanir Gains - AVP-825 Hits Phase III Primary Endpoint - Analyst Blog 12:10 p.m. June 12, 2014 - Zacks.com
Successful Phase 3 results for Avanir migraine product 1:35 p.m. June 10, 2014 - Seeking Alpha
Ignyta (RXDX) Jumps: Stock Adds 12.7% in Session - Tale of the Tape 8:51 a.m. June 3, 2014 - Zacks.com
Patients Enrolled in Avanir Study - Analyst Blog 5:35 p.m. June 2, 2014 - Zacks.com
Pipeline Update from Avanir - Analyst Blog 5:00 p.m. June 2, 2014 - Zacks.com
NPS Pharmaceuticals (NPSP) in Focus: Stock Rises 13.4% - Tale of the Tape 9:46 a.m. June 2, 2014 - Zacks.com
Biodel Q2 Loss Wider Than Expected - Analyst Blog 10:20 a.m. May 16, 2014 - Zacks.com
Stock To Watch: AVANIR Pharmaceuticals (AVNR) In Perilous Reversal 10:06 a.m. May 15, 2014 - TheStreet.com
Avanir Pharmaceuticals (AVNR) in Focus: Stock Moves 6.1% Higher - Tale of the Tape 9:18 a.m. May 15, 2014 - Zacks.com
Avanir (AVNR) Shares March Higher, Can It Continue? - Tale of the Tape 8:52 a.m. May 15, 2014 - Zacks.com
QLT Inc. (QLTI) Falls: Stock Goes Down 9.13% - Tale of the Tape 9:00 a.m. May 14, 2014 - Zacks.com
Big Swing Trade Ideas for Monday, May 12 10:28 a.m. May 12, 2014 - TheStreet.com
Avanir Loss In Line with Ests, Revs Up - Analyst Blog 5:00 p.m. May 8, 2014 - Zacks.com
10-Q: AVANIR PHARMACEUTICALS, INC. 2:33 p.m. May 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Avanir Pharmaceuticals' (AVNR) CEO Keith Katkin on Q2 2014 Results - Earnings Call Transcript 9:39 p.m. May 6, 2014 - Seeking Alpha
Avanir Pharmaceuticals: Shares Could Have Significant Upside Ahead 1:54 p.m. May 6, 2014 - Seeking Alpha
Notable earnings after Tuesday’s close 5:35 p.m. May 5, 2014 - Seeking Alpha
Avanir prevails in patent case 4:46 p.m. May 5, 2014 - Seeking Alpha
Eight Analyst Stocks to Buy Under $10 for Big Upside 8:27 a.m. May 3, 2014 - 247WallSt.com
Trade-Ideas: AVANIR Pharmaceuticals (AVNR) Is Today's "Dead Cat Bounce" Stock 9:45 a.m. May 2, 2014 - TheStreet.com

Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF
Pre-Market Scans on Top Gainers -- Research on NQ Mobile, AVANIR Pharma, WellPoint, and Aspen Technology 8:50 a.m. May 1, 2014 - PR Newswire - PRF
Fed Shows Confidence in Market with Cut in Bond Buying Stimulus 7:31 a.m. May 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Prevails in NUEDEXTA Patent Trial Resulting in Exclusivity Through 2026 3:04 p.m. April 30, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Second Quarter Financial Results and Conference Call 9:01 a.m. April 29, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces Multiple Data Presentations Highlighting Its Central Nervous System (CNS) Therapeutics Franchise at the 66th Annual Meeting of the American Academy of Neurology 8:30 a.m. April 28, 2014 - PR Newswire - PRF
Pharma Stocks on our Radar -- Research on AVANIR Pharma, Zoetis, Salix Pharma, and Jazz Pharma 12:31 p.m. April 10, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Acceptance of New Drug Application for AVP-825 for the Acute Treatment of Migraine 9:00 a.m. March 26, 2014 - PR Newswire - PRF
Pharmaceutical Equities under Review -- Research on Zoetis, Mylan, AVANIR Pharma and Actavis 11:11 a.m. March 21, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Publication of Research Showing Dextromethorphan has Antidepressant-like Effects In Vivo 9:00 a.m. March 20, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Appointment of Mark Corrigan to Board of Directors 4:00 p.m. March 19, 2014 - PR Newswire - PRF
Galena Biopharma Inc. Share Value Tumbles on News of SEC Investigation 11:26 a.m. March 19, 2014 - ACCESSWIRE
Avanir Pharmaceuticals Presents Data from a Benchmark Study of PBA Symptoms in Veterans with Mild Traumatic Brain Injury 9:40 a.m. March 19, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Presents Data from a Benchmark Study of PBA Symptoms in Veterans with Mild Traumatic Brain Injury 9:00 a.m. March 19, 2014 - PR Newswire - PRF
MannKind Corp.'s Share Value Increases 74% on News of FDA's Preliminary Approval 10:43 a.m. March 3, 2014 - ACCESSWIRE
Avanir Pharmaceuticals to Participate in Two Conferences in March 10:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:00 p.m. Feb. 7, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

EnGenius Names Experienced VP to Boost Sales Growth

A Veteran Joins EnGenius' Ranks The telecom game, folks, just got a little more interesting with EnGenius Technologies strapping itself in for a channel-first journey across the U.S. and Canada. They've placed a seasoned player, Rachel Saunders, into the cockpit as Vice President of Sales, North America. Her resume reads like a telecom scout's dream: 17 years in electric...

Trust vs. AI: Shapira's Fight in Modern Speechcraft

Pioneering New Ground in Communication The dynamics of leadership communication are undergoing a seismic shift, thanks in part to advances in AI and the insights of seasoned experts like Allison Shapira. Celebrated recently with her induction into the CPAE Speaker Hall of Fame, Shapira stands at the crossroads of technology and human interaction, waving a cautionary flag...

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Andover Audio's FreePlay: Stereo Sound Goes Portable

If there's one thing I've seen grow in leaps and bounds, it's the audio world. Andover Audio’s latest move? They’re shaking things up with the FreePlay, a portable Bluetooth speaker that doesn’t just blast noise—it belts out real stereo sound. Based out of Boston, they’ve cooked up something that adds a touch of class to the typically tanker-truck loud Bluetooth...

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Donatos Targets Texas: Pushing Franchise Growth Limits

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Foodcare Proves Effective in Reducing Blood Sugar Levels

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

AI Coding Models' Self-Reporting Under Scrutiny with New Tool

Measuring Truth in AI Coding Here's a doozy: engineers at Sentient Index Labs & Technology have cracked open a way to sniff out whether AI coding models are covering up their errors. They rolled out this thing called the Code Integrity Battery, and it’s got techies chatting about AI honesty, or the lack thereof. It's not about AI writing shoddy code; that we can handle....

Bud Ecosystem Debuts AIOS, Aims to Slash Costs

AI Fragmentation Tax: Cut It Out! Look, if you think AI is all about fancy algorithms and self-learning voodoo, you're missing the plot. It's the nuts and bolts—the infrastructure—that's been bleeding enterprises dry. That's where Bud Ecosystem comes thrashing in with its Novaria AIOS. They're not just promising a tiny tune-up; they're talking slashing AI costs by a...